youtube_live
Q3 2026 earnings • released • EPS beat +၁၆.၀၉% • Revenue beat +၂.၇၉%
See resultschevron_right
PACB:NASDAQ
Pacific Biosciences of California Inc
၂.၂၆ US$
arrow_downward
-၇.၂၀%(-၀.၁၇) 1D
၂.၂၅ US$
arrow_downward
-၀.၁၄% (-၀.၀၀၃၂)bedtimeAfter hours
Closed: နို ၆, GMT-၅ ၁၆:၀၀:၀၀ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PACB...
Open
၂.၄၃ US$
High
၂.၅၄ US$
Low
၂.၂၄ US$
Mkt. cap
၇၀.၀၉ ကုဋေ
Avg. vol.
၁.၉၀ ကုဋေ
Volume
၉.၅၆ သန်း
52-wk high
၃.၄၄ US$
52-wk low
၁.၀၇ US$
EPS
-၀.၄၃ US$
Beta
၂.၂၁
Shares outstanding
၃၁.၀၈ ကုဋေ
No. of employees
၄၈၅
Open
၂.၄၃ US$
High
၂.၅၄ US$
Low
၂.၂၄ US$
Mkt. cap
၇၀.၀၉ ကုဋေ
Avg. vol.
၁.၉၀ ကုဋေ
Volume
၉.၅၆ သန်း
52-wk high
၃.၄၄ US$
52-wk low
၁.၀၇ US$
EPS
-၀.၄၃ US$
Beta
၂.၂၁
Shares outstanding
၃၁.၀၈ ကုဋေ
No. of employees
၄၈၅
News stories
From web sources and news partners
TradingView
·
ပြီးခဲ့သည့် ၂ ရက်
Key facts: PACB Q3 Revenue Rises 6%; Barclays and Piper Sandler Raise Price Targets
GuruFocus
·
ပြီးခဲ့သည့် ၂ ရက်
PACB Reiterated by Piper Sandler -- Price Target Raised to $3.00
The Joplin Globe
·
ပြီးခဲ့သည့် ၃ ရက်
Pacific Biosciences: Q3 Earnings Snapshot
marketscreener.com
·
ပြီးခဲ့သည့် ၃ ရက်
Earnings Flash (PACB) Pacific Biosciences of California, Inc. Posts Q3 Adjusted Loss $0.11 per Share, vs. FactSet Est of $-0.13
Profile
Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing, based on the properties of zero-mode waveguides and sequencing by binding chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension. Wikipedia
About Pacific Biosciences of California Inc
CEOChristian Henry
Employees၄၈၅
Founded၂၀၀၄
HeadquartersMenlo Park, ကယ်လီဖိုးနီးယားပြည်နယ်, ယူနိုက်တက်စတိတ်
SectorHealth Care
Industry-
Websitepacb.com